Michael R. Hayden, Director at IONIS PHARMACEUTICALS INC (IONS), bought 15,000 shares at $31.86 ($478K) on 2025-05-01, disclosed to the SEC on 2025-05-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IONS | BUY | 2026-07-31 | $1.1M | — | Filing → |
| IONS | BUY | 2024-12-26 | $272K | — | Filing → |
| ABCL | BUY | 2023-09-26 | $98K | — | Filing → |